Shnayder, Natalia A.,
Grechkina, Violetta V.,
Trefilova, Vera V.,
Efremov, Ilya S.,
Dontceva, Evgenia A.,
Narodova, Ekaterina A.,
Petrova, Marina M.,
Soloveva, Irina A.,
Tepnadze, Liia E.,
Reznichenko, Polina A.,
Al-Zamil, Mustafa,
Altynbekova, Gulnara I.,
Strelnik, Anna I.,
Nasyrova, Regina F. (2023) -MetS. These metabolic biomarkers may provide the key to the development of a new multidisciplinary
personalized strategy
Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) from the standpoint of the pharmacogenomics and pharmacometabolomics. In addition, a new
personalizedNasyrova, Regina F.,
Shnayder, Natalia A.,
Osipova, Sofia M.,
Khasanova, Aiperi K.,
Efremov, Ilya S.,
Al-Zamil, Mustafa,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Garganeeva, Natalia P.,
Shipulin, German A. (2023) this risk can be partially modified by the
personalized
selection of APs and their dosing rates, taking
is to improve the efficiency of processing and use of medical data for the transition to
personalized medicine
architecture of a given disease, but also for potential applications in the field of
personalized medicine
and academic performance of students. The leading non-cognitive skills include taxonomically five
personalityGilyazova, Irina,
Enikeeva, Kadriia,
Rafikova, Guzel,
Kagirova, Evelina,
Sharifyanova, Yuliya,
Asadullina, Dilara,
Pavlov, Valentin (2023) , and
personalization of their treatment. The review describes the most significant advances in epigenetics of BLCA
Nasyrova, Regina F,
Vaiman, Elena E,
Repkina, Vera V,
Khasanova, Aiperi K,
Asadullin, Azat R,
Shipulin, German A,
Altynbekov, Kuanysh S,
Al-Zamil, Mustafa,
Petrova, Marina M,
Shnayder, Natalia A (2023) strategy for the
personalized prevention and treatment of this adverse neurological drug reaction of APs